288 related articles for article (PubMed ID: 28807567)
21. Optogenetic restoration of retinal ganglion cell activity in the living primate.
McGregor JE; Godat T; Dhakal KR; Parkins K; Strazzeri JM; Bateman BA; Fischer WS; Williams DR; Merigan WH
Nat Commun; 2020 Apr; 11(1):1703. PubMed ID: 32245977
[TBL] [Abstract][Full Text] [Related]
22. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
[TBL] [Abstract][Full Text] [Related]
23. Mini-Review: Cell Type-Specific Optogenetic Vision Restoration Approaches.
Chaffiol A; Duebel J
Adv Exp Med Biol; 2018; 1074():69-73. PubMed ID: 29721929
[TBL] [Abstract][Full Text] [Related]
24. Tropism of engineered and evolved recombinant AAV serotypes in the rd1 mouse and ex vivo primate retina.
Hickey DG; Edwards TL; Barnard AR; Singh MS; de Silva SR; McClements ME; Flannery JG; Hankins MW; MacLaren RE
Gene Ther; 2017 Dec; 24(12):787-800. PubMed ID: 28872643
[TBL] [Abstract][Full Text] [Related]
25. Channelrhodopsins: visual regeneration and neural activation by a light switch.
G N; Tan A; Farhatnia Y; Rajadas J; Hamblin MR; Khaw PT; Seifalian AM
N Biotechnol; 2013 Jun; 30(5):461-74. PubMed ID: 23664865
[TBL] [Abstract][Full Text] [Related]
26. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
[TBL] [Abstract][Full Text] [Related]
27. Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters.
Nieuwenhuis B; Laperrousaz E; Tribble JR; Verhaagen J; Fawcett JW; Martin KR; Williams PA; Osborne A
Gene Ther; 2023 Jun; 30(6):503-519. PubMed ID: 36635457
[TBL] [Abstract][Full Text] [Related]
28. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation.
Bok D; Yasumura D; Matthes MT; Ruiz A; Duncan JL; Chappelow AV; Zolutukhin S; Hauswirth W; LaVail MM
Exp Eye Res; 2002 Jun; 74(6):719-35. PubMed ID: 12126945
[TBL] [Abstract][Full Text] [Related]
29. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
Reid CA; Ertel KJ; Lipinski DM
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
[TBL] [Abstract][Full Text] [Related]
30. Optogenetics-Mediated Gene Therapy for Retinal Diseases.
Tomita H; Sugano E
Adv Exp Med Biol; 2021; 1293():535-543. PubMed ID: 33398840
[TBL] [Abstract][Full Text] [Related]
31. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C
Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina.
Grant CA; Ponnazhagan S; Wang XS; Srivastava A; Li T
Curr Eye Res; 1997 Sep; 16(9):949-56. PubMed ID: 9288458
[TBL] [Abstract][Full Text] [Related]
33. Mutation-Independent Gene Therapies for Rod-Cone Dystrophies.
Fortuny C; Flannery JG
Adv Exp Med Biol; 2018; 1074():75-81. PubMed ID: 29721930
[TBL] [Abstract][Full Text] [Related]
34. Adeno-associated virus-vectored gene therapy for retinal disease.
Dinculescu A; Glushakova L; Min SH; Hauswirth WW
Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
[TBL] [Abstract][Full Text] [Related]
35. Serotype-based evaluation of an optogenetic construct in rat cortical astrocytes.
Balachandar L; Borrego D; Diaz JR
Biochem Biophys Res Commun; 2022 Feb; 593():35-39. PubMed ID: 35051780
[TBL] [Abstract][Full Text] [Related]
36. [Expression pattern of different serotypes of adeno-associated viral vectors in mouse retina].
Hu S; Yang LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):845-850. PubMed ID: 33047717
[TBL] [Abstract][Full Text] [Related]
37. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
[TBL] [Abstract][Full Text] [Related]
38. Optogenetic approaches to therapy for inherited retinal degenerations.
De Silva SR; Moore AT
J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
[TBL] [Abstract][Full Text] [Related]
39. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration.
Rex TS; Allocca M; Domenici L; Surace EM; Maguire AM; Lyubarsky A; Cellerino A; Bennett J; Auricchio A
Mol Ther; 2004 Nov; 10(5):855-61. PubMed ID: 15509503
[TBL] [Abstract][Full Text] [Related]
40. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
